title: Avoiding bias in the conduct and reporting of cost-effectiveness research sponsored by pharmaceutical companies.
authors.forename: A L
authors.initials: AL
authors.lastname: Hillman
authors.forename: J M
authors.initials: JM
authors.lastname: Eisenberg
authors.forename: M V
authors.initials: MV
authors.lastname: Pauly
authors.forename: B S
authors.initials: BS
authors.lastname: Bloom
authors.forename: H
authors.initials: H
authors.lastname: Glick
authors.forename: B
authors.initials: B
authors.lastname: Kinosian
authors.forename: J S
authors.initials: JS
authors.lastname: Schwartz
mesh_terms: D003362:Cost-Benefit Analysis; D004345:Drug Industry; D004995:Ethics, Professional; D011287:Prejudice; D012107:Research Design; D014481:United States